Kaigene and Celltrion Forge Alliance to Develop Innovative Antibody Therapies for Autoimmune Disorders Kaigene has signed a licensing deal with Celltrion to develop advanced antibody therapeutics targeting autoimmune diseases, opening new avenues for treatment.

Kaigene and Celltrion Forge Alliance to Develop Innovative Antibody Therapies for Autoimmune Disorders #United_States #Rockville #Celltrion #antibody_therapeutics #Kaigene